|
US2012264806A1
|
|
Oligomeric compounds and excipients
|
|
US2011269818A1
|
|
Modulation of prion expression
|
|
US2010267814A1
|
|
Targeting microRNAs for the treatment of liver cancer
|
|
WO2009046426A2
|
|
Compounds and methods for improving cellular uptake of oligomeric compounds
|
|
US2009156526A1
|
|
Compositions and methods for modulation of LMNA expression
|
|
WO2007025229A2
|
|
Compositions and their uses directed to hsp27
|
|
WO2005023986A2
|
|
Microrna as ligands and target molecules
|
|
WO2005007825A2
|
|
Modulation of aminopeptidase n expression
|
|
WO2005006958A2
|
|
Modulation of ceacam1 expression
|
|
US2003083300A1
|
|
Antisense modulation of cellular inhibitor of Apoptosis-2 expression
|
